The phase 3 CONTACT-02 study was designed to evaluate the efficacy and safety of cabozantinib plus atezolizumab versus ARPI switch in patients with mCRPC and measurable extrapelvic soft-tissue ...

Aker BP announces that the Johan Sverdrup partnership has made a final investment decision for Phase 3 of the field development. The project includes new subsea infrastructure that will increase ...

Akebia Therapeutics, Inc. (NASDAQ:AKBA) is one of the 12 Small Cap Stocks with High Upside Potential. On June 4, the company published pre-specified analyses for its vadadustat global phase 3 ...

South Korean company HLB Therapeutics has announced that its US subsidiary, ReGenTree, failed to meet the primary end point in a European phase 3 trial (SEER-3) of RGN-259, a thymosin beta-4–based eye ...

VEGA-3 Phase 3 Study VEGA-3 is the second Phase 3 clinical trial evaluating the safety and efficacy of Phentolamine Ophthalmic Solution 0.75% in subjects with presbyopia. VEGA-3 is a multicenter, ...

Biogen has initiated the BRAVE study, a global Phase 3 clinical trial to evaluate omaveloxolone in children with Friedreich ataxia, addressing a critical unmet need in the pediatric population.